Full Press Release Details
Ocuphire Pharma Receives PDFUA Fee Waiver for Nyxol New Drug Application from FDA.
IRD
Ocuphire Pharma Receives PDFUA Fee Waiver for Nyxol New Drug Application from FDA
Key Takeaway: Ocuphire Pharma Receives PDFUA Fee Waiver for Nyxol New Drug Application from FDA